New Tumor Model for Cancer Research
Author Information
Author(s): T.E. Wheldon, H.C. Walker, J. Burgin, A.S. Michalowski, C. Rowlatt
Primary Institution: MRC Cyclotron Unit Hammersmith Hospital
Hypothesis
Can a new spontaneous murine tumor model provide better insights for in vitro-in vivo studies of human cancer?
Conclusion
The study introduces a new spontaneous transplantable sarcoma that is non-immunogenic and suitable for in vitro and in vivo cancer research.
Supporting Evidence
- The tumor is non-immunogenic as judged by the TD50 test.
- The tumor shows a unique infiltration pattern into adjacent tissues.
- Histological studies confirmed the tumor's evolution from osteosarcoma to fibrosarcoma-like morphology.
- The tumor can grow in both in vitro and in vivo environments.
- Plating efficiency of STS cells was found to be 40%.
Takeaway
Scientists found a new type of tumor in mice that can help them study cancer better because it doesn't trigger the immune system.
Methodology
The tumor was disaggregated enzymatically and transplanted into mice, with growth and immunogenicity assessed through various tests.
Potential Biases
C57 B/T mice are not good breeders, which may affect the study's reproducibility.
Limitations
The tumor growth pattern is irregular, making size assessment difficult.
Participant Demographics
C57B/1crfa+ ('Black and Tan') strain mice were used in the study.
Statistical Information
P-Value
1.5 x 10^2 for viable cells, 1.8 x 10^2 for irradiated cells
Confidence Interval
95% confidence limits for the median
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website